These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12833028)

  • 21. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
    Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
    Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary cutaneous peripheral T-cell lymphoma, unspecified, with CD8-positive phenotype.
    Watabe H; Kawakami T; Murakami N; Kimura S; Kannari M; Baba T; Soma Y
    Int J Dermatol; 2006 Nov; 45(11):1385-7. PubMed ID: 17076740
    [No Abstract]   [Full Text] [Related]  

  • 23. Lymphoma or pseudolymphoma: A report of six cases and review of the literature.
    Tian Z; Shiyu Z; Tao W; Li L; Yuehua L; Hongzhong J
    Dermatol Ther; 2019 Jul; 32(4):e12807. PubMed ID: 30589489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
    Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
    Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful administration of aggressive chemotherapy concomitant to tuberculostatic and highly active antiretroviral therapy in a patient with AIDS-related Burkitt's lymphoma.
    Lehmann C; Wyen C; Hoffmann C; Fätkenheuer G
    HIV Med; 2005 Jan; 6(1):51-3. PubMed ID: 15670254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
    Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary cutaneous aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma with atypical presentation.
    Kim SK; Kim YC; Kang HY
    J Dermatol; 2006 Sep; 33(9):632-4. PubMed ID: 16958809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AIDS-related non-Hodgkin's lymphoma in the first decade of highly active antiretroviral therapy.
    Palmieri C; Treibel T; Large O; Bower M
    QJM; 2006 Dec; 99(12):811-26. PubMed ID: 17085516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary cutaneous aggressive epidermotropic CD8 positive cytotoxic T-cell lymphoma of the ear.
    Fika Z; Karkos PD; Badran K; Williams RE
    J Laryngol Otol; 2007 May; 121(5):503-5. PubMed ID: 17166330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Systemic capillary leak syndrome disclosing mixed diffuse T lymphoma].
    el Wady Z; Bagot M; Wechsler J; Kalis B; Rousselot R; Deville JF; Haioun C; Farcet JP; Revuz J
    Ann Dermatol Venereol; 1991; 118(11):882-3. PubMed ID: 1789669
    [No Abstract]   [Full Text] [Related]  

  • 31. Lymphoma with large-plaque parapsoriasis treated with PUVA.
    Tamagawa R; Katoh N; Shimazaki C; Okano A; Yamada S; Ichihashi K; Masuda K; Kishimoto S
    Eur J Dermatol; 2005; 15(4):265-7. PubMed ID: 16048755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Palpable arciform migratory erythema in an HIV patient, a CD8+ pseudolymphoma.
    Muche JM; Toppe E; Sterry W; Haas N
    J Cutan Pathol; 2004 May; 31(5):379-82. PubMed ID: 15059223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of AIDS-related lymphoma.
    Levine AM
    Curr Opin Oncol; 2008 Sep; 20(5):522-8. PubMed ID: 19106654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cd38 expression on Cd8+ T cells in Human immunodeficiency virus 1-positive adults treated with HAART.
    Beran O; Holub M; Spála J; Kalanin J; Stanková M
    Acta Virol; 2003; 47(2):121-4. PubMed ID: 14524479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of primary effusion lymphoma with highly active antiviral therapy in the setting of HIV infection.
    Ripamonti D; Marini B; Rambaldi A; Suter F
    AIDS; 2008 Jun; 22(10):1236-7. PubMed ID: 18525275
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term highly active antiretroviral therapy in chronic HIV-1 infection: evidence for reconstitution of antiviral immunity.
    Jansen CA; Piriou E; De Cuyper IM; van Dort K; Lange JM; Miedema F; van Baarle D
    Antivir Ther; 2006; 11(1):105-16. PubMed ID: 16518966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary cutaneous aggressive epidermotropic cytotoxic CD8
    Cyrenne BM; Subtil A; Girardi M; Foss F
    Int J Dermatol; 2017 Dec; 56(12):1448-1450. PubMed ID: 29047111
    [No Abstract]   [Full Text] [Related]  

  • 38. [Results of radiotherapy in a case of epidermotropic cutaneous lymphoma associated with granulomatous cutis laxa].
    Nouira R; Maalej M; Zili J; Denguezli M; Belajouza C; Jomaa B
    Bull Cancer Radiother; 1994; 81(2):147-50. PubMed ID: 7702895
    [No Abstract]   [Full Text] [Related]  

  • 39. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.
    Lim ST; Karim R; Tulpule A; Nathwani BN; Levine AM
    J Clin Oncol; 2005 Nov; 23(33):8477-82. PubMed ID: 16230675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Case of highly active anti-retroviral therapy-induced immune reconstitution inflammatory syndrome in AIDS-related progressive multifocal leukoencephalopathy].
    Imamura E; Yamashita H; Fukuhara T; Sawa H; Nagashima K; Kuwabara M; Tokinobu H
    Rinsho Shinkeigaku; 2007 Oct; 47(10):650-6. PubMed ID: 18095498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.